Epidemiology and natural history of HCV infection
Datos Bibliográficos
| ID | 23347598 |
|---|---|
| Autores | Behzad Hajarizadeh (0000-0003-2212-2028, Australian Centre for HIV and Hepatitis Virology Research, autor de correspondencia), J Grebely (0000-0002-1833-2017, UNSW Sydney), Gregory J Dore (0000-0002-4741-2622, UNSW Sydney) |
| Año | 2013 |
| Volumen | 10 |
| Número | 9 |
| Páginas | 553-562 |
| Fecha de publicación | 2013-09-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Nature Reviews Gastroenterology & Hepatology (JOURNAL) |
| Identificadores de la revista | ISSN: 1759-5045 • E-ISSN: 1759-5053 |
| Editorial | Springer Science and Business Media LLC (PUBLISHER) |
| DOI | 10.1038/nrgastro.2013.107 |
| PMID | 23817321 |
| OpenAlex | W2086887894 |
| Idioma | EN |
| Citas recibidas | 56 |
| Referencias citadas | 135 |
Asymptomatic · Chronic infection · Chronic liver disease · Cirrhosis · Disease · Environmental health · Hepatitis C · Hepatitis C virus · Hepatocellular carcinoma · Immune system · Incidence (geometry) · Liver disease · Natural history · Population · Virus · Epidemiology · Hepatitis B Virus Studies · Hepatitis C virus research · Immunology · Internal Medicine · Liver Disease Diagnosis and Treatment · Medicine
Evaluation of knowledge attitude and practice towards hepatitis B and C infections and its impact among healthy volunteers in urban and rural areas of Kanyakumari District
Initiating HCV treatment with direct acting agents in opioid agonist treatment
The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use
Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990–2016
Prevalence of hepatitis C in a Swiss sample of men who have sex with men
Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda
Experiences of Hope after Treatment of Hepatitis C Infection—A Qualitative Study
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
Assessment of Health Behaviors of Patients with Hepatitis C
Burden of viral hepatitis caused by specific aetiologies in China, 1990–2016
Screening of hepatitis B and C viral infection, recognition of risk factors, and immunization of patients against hepatitis B virus
Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugal
Global burden of hepatitis C virus infection related to high body mass index and future forecast
Management of in- and out-of-hospital screening for hepatitis C
The ‘missing’ in the ‘endgame’ of hepatitis C elimination
‘I didn’t want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign
Prevalence of Hepatitis B and Hepatitis C in Migrants from Sub-Saharan Africa Before Onward Dispersal Toward Europe
Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness
Perceived Change in Quality of Life Related to Treatment of Hepatitis C Infection among People with Substance Use Disorder
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs
How the rural risk environment underpins hepatitis C risk
Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs
Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Elimination of hepatitis C virus infection among PWID
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral
Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective
Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs
Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission
Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting
HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers
Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting
Hepatitis C treatment at a Swedish needle exchange program, a successful model of care – the Actionne study
Enhancing the detection and management of acute hepatitis C virus infection
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
Hepatitis C testing in general practice settings
Opportunistic assessment and treatment of people with hepatitis C virus infection admitted to hospital for other reasons
High HCV cure rates among people who inject drugs and have suboptimal adherence
Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada
Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal
Hepatitis C elimination by 2030 through treatment and prevention
Decreasing Hepatitis C Incidence Among a Population With Repeated Tests
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010
Integrating HCV services for drug users
| Obras citantes distintas | 56 |
|---|---|
| Citas por año | 4,67 |
| Intervalo de citas | 2014 - 2025 (12) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 53 |